Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma

Compared with other epithelial ovarian carcinoma subtypes, ovarian clear cell carcinoma (OCCC) has been recognized to show chemoresistance. Therefore, new treatment modalities are required for patients with OCCC that is refractory to chemotherapy. The carcinoembryonic antigen glypican-3 (GPC3) is ex...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Suzuki, Shiro, Sakata, Jun, Utsumi, Fumi, Sekiya, Ryuichiro, Kajiyama, Hiroaki, Shibata, Kiyosumi, Kikkawa, Fumitaka, Nakatsura, Tetsuya
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5139642/
https://ncbi.nlm.nih.gov/pubmed/27999758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1238542
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados